Immediate Impact
1 by Nobel laureates 1 from Science/Nature 39 standout
Citing Papers
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment
2024 Standout
Aptamers as an approach to targeted cancer therapy
2024 Standout
Works of Monrat Chulanetra being referenced
GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.
2020
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Monrat Chulanetra | 93 | 105 | 78 | 23 | 308 | |
| Watee Seesuay | 79 | 115 | 91 | 24 | 318 | |
| Guilhem Richard | 64 | 191 | 52 | 19 | 322 | |
| Xinyu Zhuang | 55 | 81 | 82 | 27 | 355 | |
| Jonathon E. Mohl | 53 | 104 | 7 | 24 | 310 | |
| Christian Gervais | 88 | 154 | 57 | 19 | 269 | |
| Fan Jiang | 102 | 163 | 40 | 32 | 346 | |
| Patrícia Pereira Aguilar | 80 | 233 | 48 | 25 | 353 | |
| Dmitry V. Shcheblyakov | 106 | 111 | 89 | 34 | 335 | |
| Nino Rcheulishvili | 58 | 196 | 16 | 27 | 338 | |
| Eiji Terada | 114 | 104 | 24 | 30 | 345 |
All Works
Login with ORCID to disown or claim papers
Loading papers...